Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

COTTONE, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.102
EU - Europa 3.409
AS - Asia 702
OC - Oceania 16
SA - Sud America 11
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.249
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.016
IT - Italia 896
UA - Ucraina 760
CN - Cina 527
FI - Finlandia 433
DE - Germania 284
GB - Regno Unito 266
IE - Irlanda 259
RU - Federazione Russa 112
SE - Svezia 108
BE - Belgio 95
CA - Canada 85
FR - Francia 72
IN - India 53
KR - Corea 39
RO - Romania 27
NL - Olanda 23
ES - Italia 18
AU - Australia 15
CH - Svizzera 14
MY - Malesia 13
TR - Turchia 12
PL - Polonia 11
HK - Hong Kong 9
AT - Austria 7
GR - Grecia 6
IR - Iran 6
JP - Giappone 6
LB - Libano 6
UZ - Uzbekistan 6
PK - Pakistan 5
EU - Europa 4
ID - Indonesia 4
PT - Portogallo 4
BR - Brasile 3
EG - Egitto 3
IL - Israele 3
RS - Serbia 3
SG - Singapore 3
TW - Taiwan 3
CL - Cile 2
CM - Camerun 2
CZ - Repubblica Ceca 2
NO - Norvegia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
HR - Croazia 1
LU - Lussemburgo 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
VE - Venezuela 1
VN - Vietnam 1
Totale 12.249
Salva come PNG Salva come JPEG
Città #
Fairfield 1.141
Woodbridge 876
Chandler 657
Houston 615
Ashburn 531
Wilmington 466
Jacksonville 439
Ann Arbor 438
Seattle 413
Cambridge 387
Dublin 258
Palermo 211
Medford 210
Nanjing 159
Princeton 139
Altamura 126
Tulsa 107
Brussels 93
Dearborn 91
Lawrence 89
Des Moines 82
Boardman 72
San Diego 72
Montréal 61
Munich 61
Beijing 58
Mcallen 58
Shenyang 49
Nanchang 46
Venice 42
Kumar 41
Milan 39
Seongnam 37
Jiaxing 32
Tianjin 31
Redwood City 30
Hebei 28
London 27
Saint Petersburg 26
Changsha 25
Auburn Hills 22
Jinan 21
Phoenix 21
San Paolo di Civitate 21
Verona 18
San Mateo 16
Orange 13
Falls Church 12
Rome 11
Zhengzhou 11
Lanzhou 10
Los Angeles 10
Bremen 9
Den Haag 9
Indiana 9
Izmir 9
Central District 8
Guangzhou 8
New York 8
Bergamo 7
Chicago 7
Moscow 7
Ningbo 7
Norwalk 7
Petaling Jaya 7
Edinburgh 6
Taizhou 6
West Chicago 6
Atlanta 5
Düsseldorf 5
Genova 5
Haikou 5
Hangzhou 5
Islington 5
Lewiston 5
Mountain View 5
Salerno 5
Toronto 5
Charlotte 4
Kraków 4
Kunming 4
Messina 4
Milazzo 4
Multan 4
San Francisco 4
Shanghai 4
Augusta 3
Belgrade 3
Catania 3
Cedar Knolls 3
Chiswick 3
Favara 3
Glasgow 3
Kuala Lumpur 3
Marcon 3
Napoli 3
Philadelphia 3
Taipei 3
Tokyo 3
Albolote 2
Totale 8.792
Salva come PNG Salva come JPEG
Nome #
Prurigo nodularis of Hyde treated with low-dose thalidomide. 295
NUTRITION, MALNUTRITION AND DIETARY INTERVENTIONS IN INFLAMMATORY BOWEL DISEASE 272
An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C 149
Physicians' Knowledge and Application of Immunization Strategies in Patients with Inflammatory Bowel Disease: A Survey of the Italian Group for the Study of Inflammatory Bowel Disease 147
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis 145
Budesonide MMX and mesalamine to induce remission in patients with ulcerative colitis 145
JC Virus, Helicobacter pylori, and Oesophageal Achalasia: Preliminary Results from a Retrospective Case-Control Study. 144
Cyclosporine or infliximab as rescue therapy in severe 2 refractory ulcerative colitis: Early and long-term data 3 from a retrospective observational study 142
Severe acute colitis associated with CMV:a prevalence study 140
Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn's disease strictures. 137
Methodological problems in RCTs on IBD 136
Infliximab and ulcerative colitis 135
Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease study 135
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease 135
Postoperative maintenance therapy for inflammatory bowel disease 135
An Unusual Presentation of Zollinger-Ellison Syndrome 134
Oral lichen planus after certolizumab pegol treatment in a patient with Crohn's disease 133
Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseases. 133
A. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease. 130
Beclomethasone dipropionate in Crohn's ileitis: A randomised, double-blind trial. 129
The frame.shift mutation of the NOD2/Card15 gene is significantly increased in ulcerative colitis: an IG-IBD study 128
The role of portal vein thrombosis in the clinical course of inflammatory bowel diseases: report on three cases and review of the literature. 128
Complete clinical remission after high dose immune suppression and autologous hematopoietic stem cell transplantation in severe Crohn's disease refractory to immunosuppressive and immunomodulator therapy 124
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. 124
Systematic review: macrophage activation syndrome in inflammatory bowel disease 124
Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in post-operative Crohn's disease 123
Incidence of Crohn's disease and Card 15 mutation in a small township in Sicily 121
Clinical and endoscopic presentation of primary gastric lymphoma:a multicenter study 120
COULD JC VIRUS PROVOKE METASTASIS IN COLON CANCER? 120
Crohn's disease:a comparative prospective study of transabdominal ultrasonography,small intestine contrastultrasonography and small bowel enema 119
Leucocytapheresis in patients with moderate severe steroid dependant Ulcerative Colitis:clinical response without endoscopic response 119
Methodology for high-quality studies on course and prognosis of inflammatory bowel disease. 119
A rare case of ulcerative proctitis associated with type B lymphomatoid papulosis and superimposed human cytomegalovirus infection. 119
EFFICACY AND SAFETY OF ENDOSCOPIC BALLOON DILATION OF SYMPTOMATIC INTESTINAL CROHN'S DISEASE STRICTURES 118
Meta-analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohn's disease. 118
Cancer in Crohn's Disease patients treated with infliximab: A long-term multicenter matched pair study 116
Tofacitinib in active ulcerative colitis 115
Toxic megacolon and human Cytomegalovirus in a series of severe ulcerative colitis patients 115
Infliximab, azathioprine or combination therapy in the treatment of active Crohn's disease. 113
Clinical course of ulcerative colitis 112
MINIMIZING INFLIXIMAB TOXICITY IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE 111
An unusual presentation of T-lymphoma in a Crohn's 4 disease patient treated with combo therapy: We are 5 willing to take a risk of serious adverse events for a 6 doubtful benefit? 111
COLORECTAL CANCER IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: PRELIMINARY RESULTS FROM AN ONGOING CASE-CONTROL STUDY 110
Improving patients Qol:how the success of treatment can improve workability 109
Unusual perforation after balloon dilation in a Crohn's disease patient:report of a case 108
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use. 106
IL-23R determines susceptibility in Crohn's disease in a Mediterranean area 105
A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients with Crohn's Disease: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease 105
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. 101
Cancer in Infliximab-treated or untreated crohn's disease patients:a 2 years longer follow-up from a multicenter matched pair study 100
Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation. 99
Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis? 99
Infliximab to treat Crohn's disease: an update 96
Infliximab prevents Crohn's disease recurrence after ileal resection. 95
Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. 95
Early postoperative recurrence of severe crohn's disease, with colonic involvement and associated human cytomegalovirus infection, treated with oral valganciclovir and adalimumab. 94
Antibiotic treatment of Crohn's disease:results of a multicentre double blind randomized placebo controlled trial with Rifamixin 93
Investigational agents for Crohn's disease. 93
Marked impact of IL28B genotype in the natural clearance of hepatitis C virus in patients with haemoglobinopathies. 93
Infliximab in the treatment of Crohn's disease :predictors of response in an Italian multicenter open study 92
Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis 91
Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life study 90
Radiofrequency thermal ablation vs percutaneous ethanol injection for small hcc in cirrhosis:metanalysis of randomized controlled trials 90
Psychopharmacology treatment and psychological interventions in irritable bowel syndromel 88
Smoking therapy may be an extreme cure in exsmokers with steroid-dependent and resistant ulcerative colitis. 88
Intestinal permeability and Genetic determinants in patients,first degree relatives,and controls in a High incidence area's of Crohn's disease in Southern Italy 87
Calprotectin in the prediction of endoscopic post-surgical recurrence in CD 85
The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound 85
Radiologia e malattia celiaca dell'adulto 84
Placebo Therapy in Crohn's disease 84
CLINICAL COURSE OF SEVERE COLITIS: A COMPARISON BETWEEN CROHN'S DISEASE AND ULCERATIVE COLITIS. 84
PREVALENCE OF CARD15/NOD2 MUTATIONS IN SICILIAN POPULATION 83
Burden of Crohn's disease: economics and quality of life aspects in Italy. 83
Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights 81
INFLIXIMAB FOR PEDIATRIC ULCERATIVE COLITIS:A RETROSPECTIVE ITALIAN MULTICENTER STUDY 80
Is splenectomy a treatment option for aseptic abscesses in patients with Crohn's disease? 79
THE ROLE OF CARD15 MUTATIONS AND SMOKING IN THE COURSE OF DISEASE IN A MEDITERRANEAN AREA 78
Adalimumab in steroid-dependent Crohn's disease patients: Prognostic factors for clinical benefit 77
VALIDATION OF A MODIFIED MODEL OF TNBS-INDUCED COLITIS IN RATS. HOW TO INDUCE A CHEMICAL COLITIS IN RATS. 77
RADIO FREQUENCY THERMAL ABLATION VS PERCUTANEOUS ETHANOL INJECTION FORM SMALL HEPATOCELLULAR CARCINOMA IN CIRRHOSIS:META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. 76
A real life comparison of the efficacy of adalimumab versus golimumab in moderate-to-severe ulcerative colitis. A multicenter experience from the sicilian network for inflammatory bowel disease (SN-IBD) 75
CA-19 to rule out Pancreatic or Biliary Cancer among patients with cholestasis:an unsuitable ? 74
Severe cutaneous psoriasis after certolizumab pegol treatment;report of a case. 74
Gastrointestinal lesions associated with spondyloarthropathies. 74
Appropriateness of immunosupprerssive drugs in inflammatory bowel disease assessed by RAND method :Italian group for IBD position statement 73
UNRESECTABLE HEPATOCELLULAR CARCINOMA:META-ANALYSIS OD ARTERIAL EMBOLIZATION 73
NEWLY DIAGNOSED NEOPLASIA IN CROHN DISESE PATIENTS TREATED WITH INFLIXIMAB;A 1 YEAR LONGER FOLLOW UP FROM A MULTICENTER MATCHED PAIR STUDY 73
Natural history of cytomegalovirus infection in a cohort of patients diagnosed with moderate severe ulcerative colitis 71
Cytomegalovirus and Inflammmatory bowel disease:is there a link ? 71
Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study. 71
ATG16L1 contribution to Crohn's disease risk in Sicily 71
The sicilian network for inflammatory bowel disease (SN-IBD): preliminary data on efficacy of biological therapy. 70
Infliximab and newly diagnosed neoplasia in CD:a multicenter matched pair study 69
The role of NOD2/CARD15 mutation and smoking in the course of Crohn's disease in a Mediterranean area 67
Familial mediterranea fever mutations in Crohn's disease in a Mediterranea area 67
Incidence of HSV and HPV with azathioprine 67
Oral valganciclovir for coloni c dilatation in ulcerative colitis associated with Human cytomegalovirus infection 67
Long term follow-up in an incident cohort of 583 pts with CD 66
Natural history of Cytomegalovirus infection diagnosed with moderate-severe ulcerative colitis 66
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis. 66
Totale 10.536
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.004
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.004
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.174 0 0 19 37 16 179 149 32 64 120 297 261
2019/20203.657 437 179 263 337 429 528 405 224 378 150 159 168
2020/20211.844 89 179 95 202 142 63 170 102 246 179 171 206
2021/20221.472 62 376 21 51 43 54 85 67 162 199 84 268
2022/20231.948 202 365 35 185 242 260 77 185 249 23 99 26
2023/2024245 53 164 28 0 0 0 0 0 0 0 0 0
Totale 12.540